How mitochondrial DNA damage affects insulin-producing cells in diabetes
The contribution of mitochondrial DNA damage to diabetes-related beta-cell failure
This study is looking at how damage to the energy-producing parts of cells might be causing problems for insulin-making cells in people with diabetes, and it hopes to find new ways to help manage the condition better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10997111 on NIH RePORTER |
What this research studies
This research investigates the role of mitochondrial DNA damage in the failure of insulin-producing beta cells in individuals with diabetes. The project focuses on understanding how disruptions in mitochondrial function contribute to the overall decline in beta cell health and insulin production. By analyzing the mitochondrial DNA from pancreatic islets of diabetic and non-diabetic donors, the research aims to uncover the mechanisms behind beta cell dysfunction. Patients may benefit from insights that could lead to new therapeutic strategies for diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 2 diabetes who are experiencing challenges with insulin production.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve beta cell function and insulin production in diabetes patients.
How similar studies have performed: Previous research has shown that mitochondrial dysfunction is a significant factor in diabetes, suggesting that this approach could yield valuable insights.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Davidson, Rebecca K — University of Michigan at Ann Arbor
- Study coordinator: Davidson, Rebecca K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.